Zatarah, Razan
Faqeer, Nour
Mahmoud, Aseel
Quraan, Tasnim
Matalka, Lujain
Kamal, Aya
Nazer, Lama
Article History
Received: 14 August 2022
Accepted: 8 October 2022
First Online: 17 October 2022
Declarations
:
: The protocol was approved by the institutional review board of King Hussein Cancer Center (study#20 KHCC188) with waiver of consent in view of the retrospective nature of the study. The study was conducted in accordance with the Declaration of Helsinki and adhered to Good Clinical Practice guidelines.
: Not applicable.
: The authors declare no competing interests.